- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Roche Diabetes Care appoints Omar Sherief Mohammad as India, Middle East & Africa head
New Delhi: Roche has announced the appointment of Omar Sherief Mohammad as Head India, Middle East & Africa (IMEA) within the Roche Diabetes Care (RDC) Global Commercial Organisation, based in Mumbai.
Prior to this appointment, Omar has been General Manager RDC India since September 2019.
In this new capacity, Omar will play a key role in the shaping and executing of the overall commercial Go-To-Market Strategy, responsible for setting the strategic direction for IMEA, in alignment with the Global Commercial Organisation as well as the overall RDC strategy. In this newly created role, Omar will have direct oversight of IMEA and the RDC General Managers/Country Heads of these markets will directly report to him. Omar will also be General Manager in India.
Speaking about the new appointment, Omar said, "I strongly feel that there is a need for improving access to care in order to support the underprivileged section of the community by creating a holistic ecosystem for screening, awareness and education programs. I look forward to leading my teams across the IMEA region towards dedicating efforts to bend the curve of diabetes in terms of prevalence and adding value by bringing true relief for people with diabetes."
As GM India, Omar implemented a strategic patient-centric approach towards improving access to care. Under his leadership, RDC India pioneered the adoption of a Figital approach to enhance education and awareness about latest tech-enabled solutions to improve patient care.
During his tenure, the company forged meaningful partnerships with like-minded public and private players to create a comprehensive eco-system of care to support underprivileged sections of the community. On the occasion of World Diabetes Day 2020, RDC India partnered with the Maharashtra state government to donate blood glucose monitoring devices to underprivileged people in rural Maharashtra. To further support the government in this time of covid-19 crisis, last year RDC India donated money to the PM relief fund and PPE kits to BMC hospitals in Mumbai.
As head of IMEA, Omar will steer the countries under his charge to amplify this patient-centric approach and collaborate with various stakeholders to address the burden of diabetes in the region.
Omar has two decades of experience in pharmaceutical sector, primarily in diabetes care, in India, global marketing in Denmark and emerging Asian markets. Prior to joining Roche, Omar was the VP and GM of Novo Nordisk, Vietnam and other Southeast Asia emerging markets.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story